Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling

Por Maruwge, Wessen, D’Arcy, Pádraig, Folin, Annika, Brnjic, Slavica, Wejde, Johan, Davis, Anthony, Erlandsson, Fredrik, Bergh, Jonas, Brodin, Bertha
Publicado em 2008

Deletion of the Telomerase Reverse Transcriptase Gene and Haploinsufficiency of Telomere Maintenance in Cri du Chat Syndrome

Por Zhang, Anju, Zheng, Chengyun, Hou, Mi, Lindvall, Charlotta, Li, Ke-Jun, Erlandsson, Fredrik, Björkholm, Magnus, Gruber, Astrid, Blennow, Elisabeth, Xu, Dawei
Publicado em 2003

Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator

Por Erlandsson, Fredrik, Albayaty, Muna, Chialda, Ligia, Ericsson, Hans, Amilon, Carl, Nelander, Karin, Jansson‐Löfmark, Rasmus, Wernevik, Linda, Kjaer, Magnus, Bamberg, Krister, Hartleib‐Geschwindner, Judith
Publicado no Br J Clin Pharmacol (2018)

A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma

Por Rosenberg, Jonathan E., Bambury, Richard, Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Figlin, Robert A., Smith, Gregory W., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Publicado no Invest New Drugs (2013)